Ticagrelor-Induced Dyspnea: A Controllable Side Effect

被引:1
作者
Kim, Gwangsil [1 ,2 ]
Cannon, Christopher P. [2 ,3 ,4 ,5 ]
机构
[1] Inje Univ, Sanggye Paik Hosp, Coll Med, Div Cardiol,Dept Internal Med, Seoul, South Korea
[2] CPC Clin Res, Aurora, CO USA
[3] Brigham & Womens Hosp, Cardiovasc Div, Boston, MA 02115 USA
[4] Harvard Med Sch, Boston, MA USA
[5] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
关键词
clinical outcome; drug-discontinuation; dyspnea; ticagrelor; ACUTE CORONARY SYNDROME; CARDIOVASCULAR EVENTS; CLOPIDOGREL; TOLERABILITY; EFFICACY; ASPIRIN;
D O I
10.1016/j.jcin.2023.09.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2525 / 2527
页数:3
相关论文
共 19 条
[1]   Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention [J].
Angiolillo, Dominick J. ;
Cao, Davide ;
Sartori, Samantha ;
Baber, Usman ;
Dangas, George ;
Zhang, Zhongjie ;
Vogel, Birgit ;
Kunadian, Vijay ;
Briguori, Carlo ;
Cohen, David J. ;
Collier, Timothy ;
Dudek, Dariusz ;
Gibson, Michael ;
Gil, Robert ;
Huber, Kurt ;
Kaul, Upendra ;
Kornowski, Ran ;
Krucoff, Mitchell W. ;
Ielasi, Alfonso ;
Stefanini, Giulio G. ;
Pivato, Carlo A. ;
Mehta, Shamir ;
Moliterno, David J. ;
Ohman, E. Magnus ;
Escaned, Javier ;
Sardella, Gennaro ;
Sharma, Samin K. ;
Shlofmitz, Richard ;
Weisz, Giora ;
Witzenbichler, Bernhard ;
Steg, P. Gabriel ;
Pocock, Stuart ;
Mehran, Roxana .
JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (20) :2514-2524
[2]   Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events A Secondary Analysis of the PEGASUS-TIMI 54 Trial [J].
Bonaca, Marc P. ;
Bhatt, Deepak L. ;
Ophuis, Ton Oude ;
Steg, P. Gabriel ;
Storey, Robert ;
Cohen, Marc ;
Kuder, Julia ;
Im, Kyungah ;
Magnani, Giulia ;
Budaj, Andrzej ;
Theroux, Pierre ;
Hamm, Christian ;
Spinar, Jindrich ;
Kiss, Robert G. ;
Dalby, Anthony J. ;
Medina, Felix A. ;
Kontny, Frederic ;
Aylward, Philip E. ;
Jensen, Eva C. ;
Held, Peter ;
Braunwald, Eugene ;
Sabatine, Marc S. .
JAMA CARDIOLOGY, 2016, 1 (04) :425-432
[3]   Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction [J].
Bonaca, Marc P. ;
Bhatt, Deepak L. ;
Cohen, Marc ;
Steg, Philippe Gabriel ;
Storey, Robert F. ;
Jensen, Eva C. ;
Magnani, Giulia ;
Bansilal, Sameer ;
Fish, M. Polly ;
Im, Kyungah ;
Bengtsson, Olof ;
Ophuis, Ton Oude ;
Budaj, Andrzej ;
Theroux, Pierre ;
Ruda, Mikhail ;
Hamm, Christian ;
Goto, Shinya ;
Spinar, Jindrich ;
Nicolau, Jose Carlos ;
Kiss, Robert G. ;
Murphy, Sabina A. ;
Wiviott, Stephen D. ;
Held, Peter ;
Braunwald, Eugene ;
Sabatine, Marc S. ;
Morin, Suzanne ;
Dantzer, Emily ;
Acquilano, Dayle ;
McGuire, Rachael L. ;
Gannon, Joseph B. ;
Gershman, Elaine ;
Ahlbom, Ann Maxe ;
Boberg, Barbro ;
Abola, Maria Teresa ;
Ardissino, Diego ;
Aylward, Philip ;
Corbalan, Ramon ;
Dalby, Anthony ;
Diaz, Rafael ;
Hu, Dayi ;
Isaza, Daniel ;
Kamensky, Gabriel ;
Kiss, Robert ;
Kontny, Frederic ;
Lopez-Sendon, Jose ;
Medina, Felix ;
Montalescot, Gilles ;
Nicolau, Jose ;
Paolasso, Ernesto ;
Parkhomenko, Alexander .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (19) :1791-1800
[4]   The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention The ADAPT-DES Study [J].
Brener, Sorin J. ;
Kirtane, Ajay J. ;
Stuckey, Thomas D. ;
Witzenbichler, Bernhard ;
Rinaldi, Michael J. ;
Neumann, Franz-Josef ;
Metzger, D. Christopher ;
Henry, Timothy D. ;
Cox, David A. ;
Duffy, Peter L. ;
Mazzaferri, Ernest L., Jr. ;
Mehran, Roxana ;
Parvataneni, Rupa ;
Brodie, Bruce R. ;
Stone, Gregg W. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (14) :1450-1457
[5]   2023 ESC Guidelines for the management of acute coronary syndromes [J].
Byrne, Robert A. ;
Rossello, Xavier ;
Coughlan, J. J. ;
Barbato, Emanuele ;
Berry, Colin ;
Chieffo, Alaide ;
Claeys, Marc J. ;
Dan, Gheorghe-Andrei ;
Dweck, Marc R. ;
Galbraith, Mary ;
Gilard, Martine ;
Hinterbuchner, Lynne ;
Jankowska, Ewa A. ;
Juni, Peter ;
Kimura, Takeshi ;
Kunadian, Vijay ;
Leosdottir, Margret ;
Lorusso, Roberto ;
Pedretti, Roberto F. E. ;
Rigopoulos, Angelos G. ;
Gimenez, Maria Rubini ;
Thiele, Holger ;
Vranckx, Pascal ;
Wassmann, Sven ;
Wenger, Nanette Kass ;
Ibanez, Borja ;
ESC Sci Document Grp .
EUROPEAN HEART JOURNAL, 2023, 44 (38) :3720-3826
[6]   Safety, tolerability, and initial efficacy of AZD6140, the first reversivle oral adenosine diphosphate receptor antagonist, compared with clopidigrel, in patients with non-ST-segment elevation acute coronary syndrome - Primary results of the DISPERSE-2 trial [J].
Cannon, Christopher P. ;
Husted, Steen ;
Harrington, Robert A. ;
Scirica, Benjamin M. ;
Emanuelsson, Hakan ;
Storey, Robert F. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (19) :1844-1851
[7]   Adenosine-Mediated Effects of Ticagrelor Evidence and Potential Clinical Relevance [J].
Cattaneo, Marco ;
Schulz, Rainer ;
Nylander, Sven .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (23) :2503-2509
[8]   Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety [J].
Dobesh, Paul P. ;
Oestreich, Julie H. .
PHARMACOTHERAPY, 2014, 34 (10) :1077-1090
[9]   Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease [J].
Hiatt, William R. ;
Fowkes, F. Gerry R. ;
Heizer, Gretchen ;
Berger, Jeffrey S. ;
Baumgartner, Iris ;
Held, Peter ;
Katona, Brian G. ;
Mahaffey, Kenneth W. ;
Norgren, Lars ;
Jones, W. Schuyler ;
Blomster, Juuso ;
Millegard, Marcus ;
Reist, Craig ;
Patel, Manesh R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (01) :32-40
[10]   Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA [J].
Johnston, S. Claiborne ;
Amarenco, Pierre ;
Denison, Hans ;
Evans, Scott R. ;
Himmelmann, Anders ;
James, Stefan ;
Knutsson, Mikael ;
Ladenvall, Per ;
Molina, Carlos A. ;
Wang, Yongjun .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (03) :207-217